When Should We Describe Species?

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

How should we describe the benefits of palliative radiotherapy?

The value of radiotherapy for palliation is well known to oncologists but not necessarily to other physicians. Using terms such as symptom improvement ratio (sir) and number needed to treat (nnt) rather than traditional response rates might be more appropriate in describing the benefits of palliative radiotherapy to other health care professionals.

متن کامل

When Should We Use Natural Features?

Some features of computer programs can make the programs easier to use by enabling users to interact with them in the familiar ways they interact with other people. Including these features is hard, however, and doing a good job at it is even harder. We present some of these features, and compare the pros and cons of including them in a computer program. We conclude with criteria designers can ...

متن کامل

Debate: Unstable angina - When should we intervene?

The prognosis of patients who present with non-ST segment elevation acute coronary syndromes (ACS) is guarded. These patients can be risk-stratified on the basis of symptom complex, electrocardiographic ST segment depression, obvious hemodynamic compromise and particularly on the basis of serum troponin level. An elevated troponin level determines risk and also predicts the degree of benefit fr...

متن کامل

When should we measure lipoprotein (a)?

Recently published epidemiological and genetic studies strongly suggest a causal relationship of elevated concentrations of lipoprotein (a) [Lp(a)] with cardiovascular disease (CVD), independent of low-density lipoproteins (LDLs), reduced high density lipoproteins (HDL), and other traditional CVD risk factors. The atherogenicity of Lp(a) at a molecular and cellular level is caused by interferen...

متن کامل

When transgenes wander, should we worry?

It is hard to ignore the ongoing, often emotional, public discussion of the impacts of the products of crop biotechnology. At one extreme of the hype is self-rightoeus panic, and at the other is smug optimism. While the controversy plays out in the press, dozens of scientific workshops, symposia, and other meetings have been held to take a hard and thoughtful look at potential risks of transgen...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: IMA Fungus

سال: 2017

ISSN: 2210-6359

DOI: 10.1007/bf03449459